Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Information Technology
  • Business
Washingtoner

Stratum Nutrition® Announces Market Ready Dairy Free BLIS K12® and BLIS M18®
Washingtoner/10171227

Trending...
  • Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
  • Tacoma: OMWBE Active Certification Class on November 16
  • New Atlas Maps the 38 States Behind Every Conversation
26-171491
CARTHAGE, Mo. - Washingtoner -- Stratum Nutrition®, (a business of ESM Technologies), in conjunction with Blis Technologies, is pleased to announce the release of dairy-free BLIS K12® and BLIS M18® to Stratum Nutrition's ingredient science-backed portfolio. Stratum Nutrition is the North American distributor for Blis Technologies. The release of both allergen free ingredients is helpful to customers seeking to formulate dairy free, probiotic lines. Strains are available today to customers with appropriate equivalency data.

Brian Watson, CEO at Blis Technologies said, "We are pleased to offer Stratum customers Dairy Free versions of BLIS K12® and BLIS M18® recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains. We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12® and BLIS M18® that have been trusted by a wide range of customers over many years."

Blis Technologies has been the scientific leader in oral probiotics since 2002 and they continue to lead the way in oral probiotic supplements. When it comes to a healthy oral cavity, Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). Two strains are currently marketed as probiotic ingredients, BLIS K12® and BLIS M18®.

More on Washingtoner
  • AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc

BLIS K12® helps maintain ear, nose, and throat health and supports our natural immune system defenses.* It is safe and effective for children and adults and features a robust research portfolio with over 30 years of published research. BLIS M18® is a friendly bacteria that can be used in conjunction with regular oral hygiene practices to establish a healthy balance of natural bacteria in the mouth to support healthy teeth and gums and overall health.

Micah Osborne, CEO at Stratum Nutrition®, "We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions. The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy free BLIS K12® and BLIS M18®."

For more information about Stratum Nutrition® and its branded ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12® and BLIS M18®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on Washingtoner
  • Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
  • Spokane: Mayor Brown Introduces 2027-2028 Budget Proposal
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids

About Blis Technologies

Blis Technologies develops and manufactures the world's first advanced oral probiotics, BLIS K12® & BLIS M18®. Based out of New Zealand, Blis Technologies combine innovation with more than 30 years of research to provide delivery probiotic solutions for specific health areas including ears, nose, throat, teeth and gums, and skin care.  Visit www.blis.co.nz for more information.

*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.



Contact
Jacqueline Rizo
***@stratumnutrition.com


Source: Stratum Nutrition
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
  • HiLine Homes' "Building Homes & Filling Plates" Food Drive Returns to Support Local Families
  • Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • Miami Dade College and World Affairs Council of Miami announce Navarro-Cabrera scholarship
  • RPP to host first Professional Padel Week in Miami and announce the 2026 USA Awards winners
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • AI Needs Guardrails Now: A New Movement Asks People Everywhere to Take the Pledge
  • Global Leaders Convene in Seattle to Advance Responsible AI and Cross-Border Ecosystems
  • Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 282
  • Spokane: City to provide asbestos testing, host community resource meetings - 232
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process - 194
  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 158
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 131
  • Final Week to Register for Free Spokane Community Conference - 131
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 123
  • Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 108
  • Holiday Gambling Spending Expected to Rise 12% in December - 106
  • Spokane Police Respond to Fatal Stabbing in Northeast Spokane - 103

Similar on Washingtoner

  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • NECP Promotes Chertova to Senior Business Analyst
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Paraguay Expedition Offers a Different View of Human Resilience
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute